GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$62.10
Tradestie Score
59
Market Cap
$2.24B
Revenue Growth
0.3%
Analyst Upside
+6.3%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SHC
Sotera Health Company Common Stock
|
$15.74
|
$4.60B | 38.6 | 56 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$55.42
|
$3.26B | - | 62 | Compare |
|
VCYT
Veracyte, Inc.
|
$53.19
|
$2.85B | 49.7 | 62 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.37
|
$2.22B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$85.17
|
$1.77B | - | 59 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$45.51
|
$1.50B | - | 56 | Compare |
|
NEOG
Neogen Corp
|
$8.92
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.43
|
$1.23B | - | 60 | Compare |
|
NEO
NeoGenomics, Inc.
|
$11.20
|
$1.13B | - | 55 | Compare |
|
CDNA
CareDx, Inc.
|
$25.05
|
$798.40M | - | 68 | Compare |
More GRAL Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry